Sophia Koo

Ten semifinalists have been selected in the first phase of the Antimicrobial Resistance Diagnostic Challenge, a federal prize competition that will award up to a total of $20 million in prizes, subject to the availability of funds, for innovative rapid, point-of-need diagnostic tests to combat the emergence and spread of drug resistant bacteria. The semifinalists were selected for their concepts for a diagnostic based on a technical and programmatic evaluation from among 74 submissions. While semifinalists will each receive $50,000 to develop their concepts into prototypes, anyone can submit a prototype to compete in the second phase of the challenge to win up to $100,000...